Women's Health Virginia has hosted two programs to inform professional and lay audiences about the HPV vaccines, Cervarix and Gardasil, which prevent the human papillomavirus (HPV) types that cause most cervical cancers. They are highly effective in preventing the targeted HPV types in men and women, as well as the most common health problems caused by them. Despite the effectiveness, recommendations for immunizing (routinely recommended starting at 11-12 years and for 13 through 26 year-old females, and 13 through 21 year-old males who have not completed the vaccination series ); and Virginia requirements that girls to receive the series, with the first dose before entering the 6th grade (unless parents opt out), many in the targeted age range are not getting vaccinated or not receiving the full series of 3 immunizations.
Talking About HPV Vaccines
Helping Patients and Parents Make Informed Decisions
This webinar, featuring Laurie Forlano, DO, MPH, Deputy State Epidemiologist in the Virginia Department of Health, Office of Epidemiology and Paige D. Perriello, MD, FAAP , of Pediatric Associates, Charlottesville gives health care providers and other health and education professionals a greater understanding of the medical, insurance and policy issues regarding the HPV vaccines and tools for discussing the topic and addressing patients and parents’ questions and concerns.
This workshop for parents, educators and community organization leaders features Paige D. Perriello, MD, FAAP, of Pediatric Associates, Charlottesville. Dr. Perriello discusses facts about the HPV virus and its transmission; the development, safety and effectiveness of the HPV vaccines; concerns about side-effects; why the vaccines are recommended for pre-teens of 11-12; and other concerns about vaccinating pre-teen and teenage girls.